CMS Proposals, 340B Changes and Hospital Financial Pressures with Laura Dyrda

The Becker's Healthcare Podcast recently highlighted significant challenges facing health systems as they navigate proposed changes from the Centers for Medicare & Medicaid Services (CMS). During the discussion, Scott Becker emphasized the complexities of healthcare leadership, particularly in the context of financial sustainability and workforce strategy. The upcoming Becker's 14th annual CEO and CFO roundtable in Chicago, scheduled for November 2-5, aims to address these critical issues, bringing together over 1,500 attendees and nearly 400 speakers.

Laura Dierda, editor-in-chief at Becker's Healthcare, outlined key topics currently under scrutiny, notably the proposed alterations to the 340B drug pricing program. CMS is suggesting that drugs acquired under the 340B program be purchased at an average sales price minus 33.4%, a significant reduction from the current model. This change could result in a cut of approximately $4.55 billion in Medicare drug payments, affecting hospitals heavily reliant on the program for revenue, particularly those serving rural areas. Hospital leaders are advocating for minimal changes to the program to mitigate the financial impact.

Additionally, Dierda discussed the site of service differentials, where CMS proposes paying physician office rates for certain imaging services conducted at hospitals. This adjustment could lower Medicare spending but may also challenge hospitals' operational strategies. Executives are considering how to adapt to these potential financial changes.

Further complicating matters is a reported shift in hospital expenses. While labor costs had dominated discussions previously, recent trends indicate rising expenditures in drug supplies and purchase services. In light of these developments, hospitals are reevaluating their strategies to maintain financial health amidst increasing operational costs.

Overall, the health system landscape is facing profound changes that leadership is closely monitoring as they seek innovative solutions to sustain their operations and patient care capabilities.

In this episode, Laura Dyrda, Vice President, Editor-in-Chief, Becker's Healthcare, discusses proposed CMS changes to the 340B program, site-neutral payment policies, and what they could mean for hospital and ASC finances. She also shares insights on shifting hospital expense trends, including rising drug and supply costs, and how health system leaders are adapting their strategies.